Abiopharma

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwrights 27th Annual Global Investment Conference on Monday, September 8th

New Form 8-K - MIMEDX GROUP, INC. Filed: 2025-09-03 AccNo: 0001376339-25-000093 Size: 1 MB Item 7.01: Regulation FD Disclosure

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference

Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program

Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq

Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee

Agilent Technologies, Inc. - Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting

ProPhase Labs Inc. to Participate in Renmark’sVirtual Non-Deal Roadshow Series on Thursday, September 4, 2025

Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA